<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>Spartan Bioscience DNA Analyzer, DNA analysis, Real-time PCR</title>
	<atom:link href="http://www.spartanbio.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.spartanbio.com</link>
	<description></description>
	<pubDate>Sat, 31 Dec 2011 21:38:31 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6</generator>
	<language>en</language>
			<item>
		<title>Software Test and Development Engineer</title>
		<link>http://www.spartanbio.com/2011/12/software-test-and-development-engineer/</link>
		<comments>http://www.spartanbio.com/2011/12/software-test-and-development-engineer/#comments</comments>
		<pubDate>Sat, 31 Dec 2011 21:38:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Job Posting]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2333</guid>
		<description><![CDATA[Posting date: December 2011
Description:
Seeking a Software Test and Development Engineer to who will lead the testing, verification, validation, and regulatory compliance for Microsoft Windows-based and embedded software code.
Qualifications:

 University degree in Computer Science, Computer Engineering, or equivalent
 Understands best design practices for software development
 Demonstrated success in bringing code-based products to market
 Experience with supervising [...]]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/12/software-test-and-development-engineer/feed/</wfw:commentRss>
		</item>
		<item>
		<title>2011/12/6: Largest clinical trial of point-of-care DNA testing begins in Italy</title>
		<link>http://www.spartanbio.com/2011/12/2011126-largest-clinical-trial-of-point-of-care-dna-testing-begins-in-italy/</link>
		<comments>http://www.spartanbio.com/2011/12/2011126-largest-clinical-trial-of-point-of-care-dna-testing-begins-in-italy/#comments</comments>
		<pubDate>Mon, 12 Dec 2011 23:07:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[News]]></category>

		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2330</guid>
		<description><![CDATA[&#8220;Spartan Bioscience today announced the start of GENE-MATRIX—the largest clinical trial to date of point-of-care DNA testing in medicine. The randomized prospective trial will enroll 4,000 patients over 2 years at up to 40 hospitals in Italy.&#8221;
View press release
]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/12/2011126-largest-clinical-trial-of-point-of-care-dna-testing-begins-in-italy/feed/</wfw:commentRss>
		</item>
		<item>
		<title>2011/12/6: GenomeWeb. Spartan Bioscience begins Italian trial for CYP2C19 DNA test.</title>
		<link>http://www.spartanbio.com/2011/12/2012126-genomeweb-spartan-bioscience-begins-italian-trial-for-cyp2c19-dna-test/</link>
		<comments>http://www.spartanbio.com/2011/12/2012126-genomeweb-spartan-bioscience-begins-italian-trial-for-cyp2c19-dna-test/#comments</comments>
		<pubDate>Mon, 12 Dec 2011 23:01:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Media Coverage]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2326</guid>
		<description><![CDATA[“Canada&#8217;s Spartan Bioscience said this week that it has launched a clinical trial in Italy to evaluate the company&#8217;s point-of-care CYP2C19 DNA test in guiding antiplatelet therapy in cardiac stent patients.” 
View article
]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/12/2012126-genomeweb-spartan-bioscience-begins-italian-trial-for-cyp2c19-dna-test/feed/</wfw:commentRss>
		</item>
		<item>
		<title>2011/11/17: GenomeWeb. Canadian trial validates Spartan Bioscience&#8217;s point-of-care platform for PGx applications.</title>
		<link>http://www.spartanbio.com/2011/11/20111117-genomeweb-canadian-trial-validates-spartan-biosciences-point-of-care-platform-for-pgx-applications/</link>
		<comments>http://www.spartanbio.com/2011/11/20111117-genomeweb-canadian-trial-validates-spartan-biosciences-point-of-care-platform-for-pgx-applications/#comments</comments>
		<pubDate>Thu, 24 Nov 2011 21:58:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Media Coverage]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2295</guid>
		<description><![CDATA[“Spartan Bioscience has completed a validation and proof-of-concept study in Canada showing the ability of its flagship point-of-care DNA testing system to identify patients carrying the CYP2C19*2 mutation at the time of cardiac catheterization and help guide appropriate anti-platelet therapy.” 
View article
]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/11/20111117-genomeweb-canadian-trial-validates-spartan-biosciences-point-of-care-platform-for-pgx-applications/feed/</wfw:commentRss>
		</item>
		<item>
		<title>2011/11/14: MD Conference Express. Findings from the RAPID GENE trial.</title>
		<link>http://www.spartanbio.com/2011/11/20111114-md-conference-express-findings-from-the-rapid-gene-trial/</link>
		<comments>http://www.spartanbio.com/2011/11/20111114-md-conference-express-findings-from-the-rapid-gene-trial/#comments</comments>
		<pubDate>Thu, 24 Nov 2011 21:57:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Media Coverage]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2293</guid>
		<description><![CDATA[
]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/11/20111114-md-conference-express-findings-from-the-rapid-gene-trial/feed/</wfw:commentRss>
		</item>
		<item>
		<title>2011/11/9: TheHeart.org. RAPID GENE: Clopidogrel-response gene test makes point-of-care debut.</title>
		<link>http://www.spartanbio.com/2011/11/2011119-genomeweb-rapid-gene-clopidogrel-response-gene-test-makes-point-of-care-debut/</link>
		<comments>http://www.spartanbio.com/2011/11/2011119-genomeweb-rapid-gene-clopidogrel-response-gene-test-makes-point-of-care-debut/#comments</comments>
		<pubDate>Thu, 24 Nov 2011 21:55:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Media Coverage]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2290</guid>
		<description><![CDATA[“A genotyping assay device billed as ‘the first point-of-care genetic test in medicine,’ which produces a result within 60 minutes, seems to accurately identify patients who carry a gene variant that signals reduced responsiveness to clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-Aventis).” 
View article
]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/11/2011119-genomeweb-rapid-gene-clopidogrel-response-gene-test-makes-point-of-care-debut/feed/</wfw:commentRss>
		</item>
		<item>
		<title>2011/11/3: First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy</title>
		<link>http://www.spartanbio.com/2011/11/2011113-first-clinical-trial-of-point-of-care-dna-testing-in-medicine-enables-cardiac-stent-patients-to-receive-personalized-antiplatelet-therapy/</link>
		<comments>http://www.spartanbio.com/2011/11/2011113-first-clinical-trial-of-point-of-care-dna-testing-in-medicine-enables-cardiac-stent-patients-to-receive-personalized-antiplatelet-therapy/#comments</comments>
		<pubDate>Thu, 24 Nov 2011 21:32:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[News]]></category>

		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2286</guid>
		<description><![CDATA[“Spartan Bioscience today announced data from the RAPID GENE study showing that point-of-care DNA testing successfully identified patients carrying the CYP2C19*2 gene at the time of cardiac catheterization. Cardiologists were then able to prescribe antiplatelet therapy according to the patient’s genotype. This personalized medicine approach completely eliminated high on-treatment platelet reactivity (HPR) in CYP2C19*2 carriers.”
View [...]]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/11/2011113-first-clinical-trial-of-point-of-care-dna-testing-in-medicine-enables-cardiac-stent-patients-to-receive-personalized-antiplatelet-therapy/feed/</wfw:commentRss>
		</item>
		<item>
		<title>American Heart Association Scientific Sessions</title>
		<link>http://www.spartanbio.com/2011/09/american-heart-association-scientific-sessions/</link>
		<comments>http://www.spartanbio.com/2011/09/american-heart-association-scientific-sessions/#comments</comments>
		<pubDate>Thu, 29 Sep 2011 19:26:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Trade Shows]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2252</guid>
		<description><![CDATA[Orlando, Florida / November 13-15, 2011 / Booth 1655
http://scientificsessions.org/
]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/09/american-heart-association-scientific-sessions/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Transcatheter Cardiovascular Therapeutics Conference</title>
		<link>http://www.spartanbio.com/2011/09/transcatheter-cardiovascular-therapeutics-conference/</link>
		<comments>http://www.spartanbio.com/2011/09/transcatheter-cardiovascular-therapeutics-conference/#comments</comments>
		<pubDate>Thu, 29 Sep 2011 19:24:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Trade Shows]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2250</guid>
		<description><![CDATA[San Francisco, California / November 8-10, 2011 / Booth 1336/1338
http://www.tctconference.com/
]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/09/transcatheter-cardiovascular-therapeutics-conference/feed/</wfw:commentRss>
		</item>
		<item>
		<title>World Medical Tourism and Global Healthcare Congress</title>
		<link>http://www.spartanbio.com/2011/09/world-medical-tourism-and-global-healthcare-congress/</link>
		<comments>http://www.spartanbio.com/2011/09/world-medical-tourism-and-global-healthcare-congress/#comments</comments>
		<pubDate>Thu, 29 Sep 2011 19:21:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Trade Shows]]></category>

		<guid isPermaLink="false">http://www.spartanbio.com/?p=2247</guid>
		<description><![CDATA[Chicago, Illinois / October 25-28, 2011 / Booth 82-83
http://www.medicaltourismcongress.com/
]]></description>
		<wfw:commentRss>http://www.spartanbio.com/2011/09/world-medical-tourism-and-global-healthcare-congress/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

